Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease

被引：2
|
作者：
Barkin, Jodie A. [1 ]
Deshpande, Amar R. [1 ]
机构：
[1] Univ Miami, Leonard M Miller Sch Med, Dept Med, Div Gastroenterol, 1120 NW 14th St,Clin Res Bldg,Suite 1116 D-49, Miami, FL 33136 USA
来源：
ACG CASE REPORTS JOURNAL | 2016年 / 3卷 / 02期
关键词：
D O I：
10.14309/crj.2016.15
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.
引用
下载
收藏
页码：107 / +
页数：2
相关论文
共 50 条
  • [1] Ustekinumab in the Successful Treatment of Refractory Esophageal Crohn's Disease
    Barkin, Jodie A.
    Deshpande, Amar R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S288 - S288
  • [2] Successful treatment of refractory esophageal Crohn's disease with infliximab
    Fefferman, DS
    Shah, SA
    Alsahlil, M
    Gelrud, A
    Falchulk, KR
    Farrell, RJ
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (08) : 1733 - 1735
  • [3] LETTER: SUCCESSFUL TREATMENT OF REFRACTORY ESOPHAGEAL CROHN's DISEASE WITH INFLIXIMAB
    David S. Fefferman
    Samir A. Shah
    Mazen Alsahlil
    Andres Gelrud
    Kenneth R. Falchulk
    Richard J. Farrell
    Digestive Diseases and Sciences, 2001, 46 : 1733 - 1735
  • [4] Treatment of refractory cutaneous Crohn's disease with ustekinumab
    Patel, B. M.
    Rivers, C. Ramos
    Koutroumpakis, F.
    Ahsan, M.
    Dueker, J.
    Hashash, J.
    Johnston, E.
    Barrie, A.
    Harrison, J.
    Schwartz, M.
    Babichenko, D.
    Tang, G.
    Binion, D. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S72 - S72
  • [5] Successful Treatment of Oral Crohn's Disease by Ustekinumab
    Jukema, Jelmer B.
    Brandse, Johannan F.
    de Boer, Nanne K. H.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (03) : E19 - E19
  • [6] Ustekinumab shows promise in the treatment of refractory Crohn's disease
    Katrina Ray
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (12) : 690 - 690
  • [7] Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease
    Madarame, Akira
    Kimura, Hideaki
    Kunisaki, Reiko
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (04): : 569 - 570
  • [8] Successful Use of Thalidomide for Refractory Esophageal Crohn's Disease
    Barkin, Jodie A.
    Schonfeld, Wayne B.
    Deshpande, Amar R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (05): : 855 - 857
  • [9] Ustekinumab in Treatment of Refractory Paediatric Crohn Disease
    Cameron, F. L.
    Garrick, V.
    Russell, R. K.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (03): : E30 - E30
  • [10] Ustekinumab in Treatment of Crohn's Disease Patients with Refractory Disease: Case Series
    Truta, Brindusa
    Terdiman, Jonathan
    Mahadevan-Velayos, Uma
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S359 - S360
12345